Jingrong Jean Cui
President and CEO at BlossomHill Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 months
- Director since
- 2026
3 months of board service in total across 1 board, counting each seat separately. Longest: BlossomHill Therapeutics Inc., 3 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | BlossomHill Therapeutics Inc. | Derivative conversion | +1,600,682 | — | — |
| Aug 10, 2026 | BlossomHill Therapeutics Inc. | Derivative conversion | +113,435 | — | — |
| Aug 10, 2026 | BlossomHill Therapeutics Inc. | Derivative conversion | +124,779 | — | — |
Questions about Jingrong Jean Cui
What boards is Jingrong Jean Cui on?
Jingrong Jean Cui sits on the board of BlossomHill Therapeutics Inc.
What company is Jingrong Jean Cui the CEO of?
Jingrong Jean Cui has been President and CEO of BlossomHill Therapeutics Inc. since August 2026.
How long has Jingrong Jean Cui served on boards?
Our records show at least 3 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.